Beghou expands New York and Boston offices as data, analytics, and AI teams grow

Nov 17 2026

New offices double Beghou’s footprint in key life sciences markets as demand intensifies for deeper commercialization expertise and coordinated support across strategy, analytics, and execution 

EVANSTON, Ill. –  Nov. 17, 2026  /PRNewswire/ – Beghou, a life sciences commercialization consulting and technology company, today announced new, larger offices in New York and Boston to accommodate its growing teams and capabilities in areas like data management, commercial analytics, market access, and launch excellence. 

Together with its recent expansions in Pune, Bengaluru, and Hyderabad, India, these new offices reflect Beghou’s continued investment in the people and technology solutions addressing clients’ complex commercialization needs. Beghou’s global workforce has more than doubled since 2024. 

“Clients are asking us to take on broader and more sophisticated commercialization work as they navigate increasing complexity, disruption, and data challenges,” said Adrienne Lovink, CEO of Beghou. “This growth in New York and Boston is representative of our focus on complementary, specialized teams and technology-enabled solutions that can deliver deeply integrated data, analytics, and AI strategies and executions for clients.” 

Beghou’s expanded New York office, located at 88 Pine Street in Lower Manhattan, is roughly twice as large as its prior office. 

image020Beghou Expands New York and Boston Offices as Data, Analytics, and AI Teams Grow

“New York provides access to a vast pool of talent we can draw on for our growing data management team and as we expand our depth in omnichannel and market access,” said Justin Khalifa, partner and New York lead at Beghou. “These offices are also close to many of our important clients, giving us even more opportunities to collaborate in person.” 

In Boston, Beghou is moving to a larger location at 70 Federal Street, where the company has maintained an office since entering the market in 2020. 

“Boston and Cambridge have a high concentration of the innovative life sciences and pharmaceutical companies Beghou loves to work with,” said Kevin Frymire, partner and Boston office lead at Beghou. “This larger space gives us more opportunities to engage with them, along with the universities and technology that make this such an important market. It also provides greater capacity for our growing AI and commercial analytics capabilities, with enhanced spaces for learning, training, and development that allow for greater coordination across teams.” 


About Beghou 

Beghou drives commercialization that works for life sciences. For over 30 years, Beghou has been a long-term consulting and technology partner to more than 250 life sciences clients. We connect the dots between strategy, data, technology, and teams - helping clients accelerate launches, deepen customer engagement, and advance patient access. Whether a company is pre-commercial building from scratch or in-market and refining its strategy, Beghou provides fresh ideas and pragmatic, tech-enabled solutions to help them adapt and thrive in increasing complexity.   

We build enduring partnerships by remaining engaged and accountable far beyond project delivery to ensure solutions take hold and work. We achieve faster results and lasting impact using the right mix of strategic thinking, technical expertise, and hands-on collaboration and execution. Once you’ve worked with Beghou, you’ll have an ally at every step of your career.